HIGHLIGHTS
- who: Peter Mazzone and collaborators from the Editor:, Inha University Hospital, Department of Pulmonary Medicine, Cleveland Clinic, Respiratory Institute, Cleveland, OH, United States have published the article: Clinical validation and utility of Percepta GSC for the evaluation of lung cancer, in the Journal: PLOS ONE of 13/07/2022
- what: The study showed that down-classification by Percepta GSC can reduce invasive procedures by 50% in this population.
- how: The number of invasive procedures in patients with pre-test low- or intermediate- risk benign lesions who were down-classified by the Percepta GSC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.